CRL Snapshot
Charles River Laboratories International, Inc., is an American pharmaceutical company specializing in a variety of preclinical and clinical laboratory, gene therapy and cell therapy services for the Pharmaceutical, Medical device and Biotechnology industries. It also supplies assorted biomedical products and outsourcing services for research and development in the pharmaceutical industry and offer support in the fields of basic research, drug discovery, safety and efficacy, clinical support, and manufacturing.
VALUATION DATA
Market Capitalization$13,832,096,000
Price to Sales6.00
Earnings per Share$9.2100
PE Ratio29.25
PRICE DATA
Most Recent Close$270.9500
52 Week High$3.35
52 Week Low$3.846
50-Day Moving Average$4.025
200-Day Moving Average$16.1
All data are from Alpha Vantage as of today. For more infomation on CRL see Stock Dividend, Valuation, Price and Financial Data for Investors